Study of trans arterial chemo-embolization for primary or metastatic lung cancer
Phase 3
Recruiting
- Conditions
- Stage III/IV lung cancer or metastatic lung cancer, which are unresectable and refractory to standard chemotherapy
- Registration Number
- JPRN-UMIN000038186
- Lead Sponsor
- Kashiwa Kousei General Hospital, Department of Thoracic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with anaphylaxis for contrast medium.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method For non-resectable stage III/IV lung cancer or metastatic lung cancer, which are located at mediastinum or lung hilum and refractory to standard chemotherapy, or those tumors in elderly patients, trans arterial cheemo-embolization via bronchial artery is conducted each 3 weeks with 3 courses at minimum, of which efficacy and prognosis are investigated.
- Secondary Outcome Measures
Name Time Method Accidental embolization at the non-target organs is investigated.